Eriodyctiol induces cell cycle arrest and apoptosis of LC cells by targeting the poly ADP-ribose polymerase (PARP), Bcl-2, and BCL2-associated X (Bax) signaling [154]. Here, BCL2 is linked to laryngotracheoesophageal cleft.